ELI LILLY & Co is 302.7x more valuable than Edgewise Therapeutics, Inc. by market capitalization ($1.072 T vs $3.54 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EWTX | LLY |
|---|---|---|
| Market cap | $3.54 B | $1.072 T |
| US-listed rank | #1678 | #10 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$167.79K | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 384 | 989 |
ELI LILLY & Co is 302.7x more valuable than Edgewise Therapeutics, Inc. by market capitalization ($1.072 T vs $3.54 B).
Full pages: Edgewise Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.